Literature DB >> 28408459

EPCR expression marks UM171-expanded CD34+ cord blood stem cells.

Iman Fares1, Jalila Chagraoui1, Bernhard Lehnertz1, Tara MacRae1, Nadine Mayotte1, Elisa Tomellini1, Léo Aubert2, Philippe P Roux2,3, Guy Sauvageau1,4,5.   

Abstract

A small subset of human cord blood CD34+ cells express endothelial protein C receptor (EPCR/CD201/PROCR) when exposed to the hematopoietic stem cell (HSC) self-renewal agonist UM171. In this article, we show that EPCR-positive UM171-treated cells, as opposed to EPCR-negative cells, exhibit robust multilineage repopulation and serial reconstitution ability in immunocompromised mice. In contrast to other stem cell markers, such as CD38, EPCR expression is maintained when cells are introduced in culture, irrespective of UM171 treatment. Although engineered overexpression of EPCR fails to reproduce the effects of UM171 on HSC activity, its expression is required for the repopulating activity of human HSCs. Altogether, our results indicate that EPCR is a reliable and cell culture-compatible marker of UM171-expanded human cord blood HSCs.
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28408459     DOI: 10.1182/blood-2016-11-750729

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  60 in total

1.  Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic coculture.

Authors:  Michael G Daniel; David Sachs; Jeffrey M Bernitz; Yesai Fstkchyan; Katrina Rapp; Namita Satija; Kenneth Law; Foram Patel; Andreia M Gomes; Huen-Suk Kim; Carlos-Filipe Pereira; Benjamin Chen; Ihor R Lemischka; Kateri A Moore
Journal:  FEBS Lett       Date:  2019-10-12       Impact factor: 4.124

Review 2.  Revolutionizing immunology with single-cell RNA sequencing.

Authors:  Haide Chen; Fang Ye; Guoji Guo
Journal:  Cell Mol Immunol       Date:  2019-02-22       Impact factor: 11.530

3.  A latent subset of human hematopoietic stem cells resists regenerative stress to preserve stemness.

Authors:  Kerstin B Kaufmann; Andy G X Zeng; Etienne Coyaud; Laura Garcia-Prat; Efthymia Papalexi; Alex Murison; Estelle M N Laurent; Michelle Chan-Seng-Yue; Olga I Gan; Kristele Pan; Jessica McLeod; Héléna Boutzen; Sasan Zandi; Shin-Ichiro Takayanagi; Rahul Satija; Brian Raught; Stephanie Z Xie; John E Dick
Journal:  Nat Immunol       Date:  2021-05-06       Impact factor: 25.606

4.  EPCR: a novel marker of cultured cord blood HSCs.

Authors:  Gaëlle H Martin; Christopher Y Park
Journal:  Blood       Date:  2017-06-22       Impact factor: 22.113

5.  UM171 induces a homeostatic inflammatory-detoxification response supporting human HSC self-renewal.

Authors:  Jalila Chagraoui; Bernhard Lehnertz; Simon Girard; Jean Francois Spinella; Iman Fares; Elisa Tomellini; Nadine Mayotte; Sophie Corneau; Tara MacRae; Laura Simon; Guy Sauvageau
Journal:  PLoS One       Date:  2019-11-08       Impact factor: 3.240

Review 6.  Endothelial cell protein C receptor-dependent signaling.

Authors:  Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Curr Opin Hematol       Date:  2018-05       Impact factor: 3.284

7.  Endothelial protein C receptor (EPCR) expression marks human fetal liver hematopoietic stem cells.

Authors:  Agatheeswaran Subramaniam; Mehrnaz Safaee Talkhoncheh; Mattias Magnusson; Jonas Larsson
Journal:  Haematologica       Date:  2018-07-19       Impact factor: 9.941

8.  Protein C receptor stimulates multiple signaling pathways in breast cancer cells.

Authors:  Daisong Wang; Chunye Liu; Jingqiang Wang; Yingying Jia; Xin Hu; Hai Jiang; Zhi-Ming Shao; Yi Arial Zeng
Journal:  J Biol Chem       Date:  2017-12-07       Impact factor: 5.157

9.  EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.

Authors:  Jhansi Magisetty; Usha R Pendurthi; Charles T Esmon; L Vijaya Mohan Rao
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

Review 10.  Haematopoietic stem cell self-renewal in vivo and ex vivo.

Authors:  Adam C Wilkinson; Kyomi J Igarashi; Hiromitsu Nakauchi
Journal:  Nat Rev Genet       Date:  2020-05-28       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.